Prelude Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $686k | 161k | 4.27 |
| 2023-09-30 | $496k | 161k | 3.09 |
| 2023-06-30 | $362k | 80k | 4.50 |
| 2023-03-31 | $162k | 28k | 5.70 |
| 2022-12-31 | $172k | 28k | 6.04 |
| 2022-09-30 | $185k | 28k | 6.50 |
| 2022-06-30 | $148k | 28k | 5.20 |
| 2022-03-31 | $196k | 28k | 6.89 |
| 2021-12-31 | $354k | 28k | 12.45 |
| 2021-09-30 | $889k | 28k | 31.26 |
| 2021-06-30 | $911k | 28k | 32.03 |
| 2021-03-31 | $1.2M | 28k | 43.32 |
| 2020-12-31 | $1.6M | 23k | 71.57 |
| 2020-09-30 | $678k | 23k | 30.12 |